Canadian Urological Association (CUA) - podcast cover

Canadian Urological Association (CUA)

Canadian Urological Association / L'Association des urologues du Canadacua.simplecast.com
The official podcast of the Canadian Urological Association (CUA). Le podcast officiel de l'association des urologues du Canada (AUC).
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Practice Changing Publications (PCP): Update in Kidney Cancer

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position: Kidney Cancer Canada Luke Lavallee Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas Grant/Honorarium: Sanofi

Feb 01, 20221 hr 3 minEp. 30

Practice Changing Publications (PCP): Female Urology

Disclosures: Martine Jolivet Advisory Board and/or Speaker Bureau: Allergan/Abbvie Genevieve Nadeau Clinical Trials: Contiform International Advisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma

Dec 07, 202152 minEp. 28

Management of Medication-Refractory Overactive Bladder (OAB)

Disclosures: Kevin Carlson Advisory Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie

Nov 24, 20211 hr 10 minEp. 26

Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (English)

Disclosures: Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayer Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership Position: Point Biopharma Urban Emmenegger Advisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Payment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Grant/Honorarium: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Clinical Tria...

Nov 18, 20211 hr 9 minEp. 25

V2P2 2022 - Female Sexual Dysfunction

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

Nov 15, 20211 hrEp. 22

V2P2 2022 - Female Sexual Dysfunction [FR]

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

Nov 15, 20211 hrEp. 23

CUA Practice Changing Publications (PCP): TESTIS CANCER

Disclosures: Armin Aprikian Advisory boards: Abbvie, Astellas, Bayer Grant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSera Robert Hamilton Advisory boards: Janssen, Astellas, Bayer, TerSera Clinical Trials: Janssen, Bayer, Astellas

Nov 02, 20211 hr 1 minEp. 21

CUA Highlights of ESMO 2021 - Bladder Cancer Session

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

Sep 22, 202129 minEp. 15

CUA Highlights of ESMO 2021 - Prostate Cancer Session

Disclosures: Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAA Andrea Kokorovic No disc...

Sep 22, 202148 minEp. 16

CUA Highlights of ESMO 2021 - Prostate Cancer Session - French

Disclosures: Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAA Andrea Kokorovic No disc...

Sep 22, 202148 minEp. 19

CUA Highlights of ESMO 2021 - Bladder Cancer Session - French

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

Sep 22, 202129 minEp. 18

Milestones in Advanced Bladder Cancer

Podcast Host Disclosures: Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada. Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche/Genentech, and TerSera; and has received research funding from...

Jul 12, 202127 minEp. 13

CUA Highlights of ASCO 2021 - Kidney Cancer Session - French

Disclosures: Daniel Heng Consultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, Ipsen Anand Swaminath Advisory board: Astrazeneca Expert Speaker: Astrazeneca, BMS, Eisai Grants (in kind): BMS, Roche Rodney Breau No disclosures

Jun 09, 202153 minEp. 11

CUA Highlights of ASCO 2021 - Kidney Cancer Session

Disclosures: Daniel Heng Consultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, Ipsen Anand Swaminath Advisory board: Astrazeneca Expert Speaker: Astrazeneca, BMS, Eisai Grants (in kind): BMS, Roche Rodney Breau No disclosures

Jun 09, 202152 minEp. 8

CUA Highlights of ASCO 2021 - Prostate Cancer Session

Disclosures: Brita Danielson Honoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, Janssen Nazanin Fallah-Rad Consultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeutics Honorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, Merck Travel Grants: Nekktar Therapeutics Vincent Fradet Consultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi...

Jun 09, 202159 minEp. 7

CUA Highlights of ASCO 2021 - Bladder Cancer session - French

Disclosures: Fabio Cury Educational grants: Sanofi S.A., Boston Scientific Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayey Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership position: Point Biopharma Di (Maria) Jiang Speaker's honoraria: Ipsen, Janssen, Bayer...

Jun 09, 20211 hrEp. 12

CUA Highlights of ASCO 2021 - Prostate Cancer Session - French

Disclosures: Brita Danielson Honoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, Janssen Nazanin Fallah-Rad Consultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeutics Honorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, Merck Travel Grants: Nekktar Therapeutics Vincent Fradet Consultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi...

Jun 09, 202159 minEp. 10

CUA Highlights of ASCO 2021 - Bladder Cancer session

Disclosures: Fabio Cury Educational grants: Sanofi S.A., Boston Scientific Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayey Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership position: Point Biopharma Di (Maria) Jiang Speaker's honoraria: Ipsen, Janssen, Bayer...

Jun 09, 20211 hrEp. 9

Practice Changing Publications (PCP): Management of MIBC

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase Ross Mason Advisory Boards: Astellas, Abbvie, TerSara, Verity Grants/Honoraria: Abbvie, Sanofi, TerSara, Bladder Cancer Canada Clinical Trials: Merck, Bayer

Apr 01, 20211 hrEp. 4

Practice Changing Publications (PCP): Urolithiasis

Disclosures: Andrea G. Lantz Powers none Ben Chew Consultant: Bard Medical, Boston Scientific, Cook Medical, Olympus, Poly-Med, Adva-TEC inc., Auris Surgical, Coloplast Speakers Bureau: Boston Scientific, Cook Medical, Olympus, Coloplast Grants: Boston Scientific, Cook Medical, Olympus Clinical Trials: Olympus, Bosotn Scientific, Cook Medical

Mar 01, 20211 hr 1 minEp. 3

Simplifying mCSPC: Improving Patient Management and Outcomes

Disclosures: Ricardo Rendon Advisory Board: Astellas, Amgen, Abbvie, Janssen, Bayer, AstraZeneca, Ferring, Sanofi Speakers Bureau: Astellas, Amgen, Ferring, Janssen Clinical Trials: Amgen, Astellas, Abbvie, Ferring, Janssen, AstraZeneca, Sanofi, Pfizer, Myovant

Feb 24, 202140 minEp. 2
For the best experience, listen in Metacast app for iOS or Android